# A Study Investigating [14C]-Labeled RO7269162 in Healthy Male Participants

> **NCT06733298** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 8 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** [ 14C]-labeled RO7269162

## Key facts

- **NCT ID:** NCT06733298
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-08
- **Primary completion:** 2025-01-29
- **Final completion:** 2025-01-29
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06733298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06733298, "A Study Investigating [14C]-Labeled RO7269162 in Healthy Male Participants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06733298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*